Impact of regulatory interventions to restrict the combined use of renin-angiotensin system-acting agents in Denmark: interrupted time series analysis

First published 22/12/2020

Last updated 11/01/2022

EU PAS number:

EUPAS38752

Study

Finalised

Documents

Study protocol

Initial protocol

DUS of RAS-acting agents

English (377.41 KB - PDF)View document

Study results

Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers

English (574.59 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs